LONG-TERM EFFICACY OF A PEN INJECTOR

被引：6

作者：

DINNEEN, SF

CRONIN, CC

OSULLIVAN, DJ

机构：

[1] Department of Medicine, Cork Regional Hospital, Wilton, Cork

来源：

IRISH JOURNAL OF MEDICAL SCIENCE | 1991年 / 160卷 / 09期

关键词：

D O I：

10.1007/BF02948414

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We assessed the long term efficacy of Novopen as a form of insulin administration. Records were obtained on 48 patients who were treated with Novopen between January '86 and October '88. Six patients were excluded due to insufficient data. The study group of 42 patients comprised 22 females and 20 males of average age 33 years (range 17-66). Mean Hb.A1 rose from 10.6% to 12.1% after Novopen therapy, a rise of 14.1%. This rise is both clinically and statistically significant (p < 0.001; 99% confidence limits 0.59-2.78). Increases in weight and insulin dose were also noted, but did not reach statistical significance. The majority of patients felt Novopen was superior to twice daily insulin in terms of ease of administration (81%) and flexibility of lifestyle (95%), and all who were using Novopen wished to continue with it. More than 50% of patients admitted to altering their dietary habits while using Novopen. Despite continuing patient satisfaction with this form of insulin administration, its long-term use may be associated with sub-optimal metabolic control.

引用

页码：286 / 287

页数：2

共 6 条

[1]

Dahl, Brinchmann-Hansen O., Hanssen K.F., Et al., Effect of near normoglycaemia for two years on progression of early diabetic retrinopathy, nephropathy and neuropathy: The Oslo Study, Br. Med. J., 293, pp. 1195-1199, (1986)

[2]

Reeves M.L., Seigler D.E., Ryan E.A., Skyler J.S., Glycemic control in insulin-dependent diabetes mellitus, Am. J. Med., 72, pp. 673-680, (1982)

[3]

Berger A.S., Saurbrey N., Kuhl C., Villuen J., Clinical experience with a new device that will simplify insulin injections, Diabetes Care, 6, pp. 73-76, (1985)

[4]

Walters D.P., Smith P.A., Marteau T.M., Brimble A., Borthwick L.J., Experience with Novopen, an injection device using cartridged insulin, for diabetic patients, Diabetic Med., 2, pp. 496-497, (1985)

[5]

Jensen T., Moller L., Anderson O.O., Metabolic control and patient acceptability of multiple insulin injections using Novopen cartridge-packed insulin, Practical Diabetes, 3, pp. 302-306, (1986)

[6]

Murray D.P., Kennan P., Gayer E., Dalmon P., Tomkin G.H., Drury M.L., O'Sullivan D.J., A randomised trial of the efficacy and acceptability of a pen injector, Diabetic Med., 5, pp. 750-754, (1988)

← 1 →